A detailed history of Frazier Financial Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 271 shares of NVS stock, worth $26,666. This represents 0.02% of its overall portfolio holdings.

Number of Shares
271
Previous 431 37.12%
Holding current value
$26,666
Previous $45.9 Million 32.07%
% of portfolio
0.02%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$106.13 - $120.89 $16,980 - $19,342
-160 Reduced 37.12%
271 $31.2 Million
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $16,292 - $18,897
176 Added 69.02%
431 $45.9 Million
Q4 2023

Feb 09, 2024

BUY
$92.27 - $101.54 $23,528 - $25,892
255 New
255 $25.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.